Document is current
Any future updates will be listed below
-
Authors
van den Helder, Jantine
van Dronkelaar, Carliene
Tieland, Michael
Mehra, Sumit
Dadema, Tessa
Visser, Bart
Kröse, Ben J. A.
Engelbert, Raoul H. H.
Weijs, Peter J. M.
-
Funding
Funding for this research was provided by:
Amsterdam University of Applied Sciences
Fonds NutsOhra (101323)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (023.006.013)
- License Information
-
More Information
Article History
Received: 9 October 2017
Accepted: 19 July 2018
First Online: 14 August 2018
Ethics approval and consent to participate
: The study is approved by the Medical Ethics Committee (METC) of the VU University Medical Center (VUmc) in The Netherlands. (Protocol ID: VUMC2016_025, submitted protocol version 4.0). The METC has identified the VITAMIN-application as a class I Medical Device, used for clinical trial purposes. Written informed consent is obtained from all participants before inclusion. The research is performed according to the Dutch Medical Research Involving Human Subjects Act and principles of the Declaration of Helsinki (64th W MA General Assembly, Fortaleza, Brazil, October 2013).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
